Featured in this edition of ISpeak iSpeak Reading Roundup are the top blog posts from June 2019. Explore critical- industry initiatives, membership Membership highlights, and more for what the pharmaceutical industry was reading last month.
The incorporation of statistical evaluations and scientific approaches supports the biopharma world in developing successful process validation techniques. The world of biopharmaceuticals is advancing along with the process knowledge and understanding of manufacturers. Learn more about these cutting-edge developments and biopharma innovation.
GMP bioprocessing includes crucial attributes that must actively be monitored and controlled during observation and process validation. The Continued Process verification plan aims to eliminate risks in production and to increase regulatory approval. See the primary points that influence bioprocess and new parameters on the market.
Buket has been involved with ISPE since her time in college at Istanbul University. While pursuing her skills and interest in pharmaceuticals, she stayed connected to ISPE through the Turkey Affiliate’s efforts to increase pharmaceutical knowledge and opportunity. Find out how ISPE membership can further both career and personal development.
“WFI production is a critical part of any parenteral drug process. There are several factors that need to be considered when selecting WFI production methods, such as capacity, future needs, storage, and quality control.” Discover water for injection innovations with this technology overview.
The objective for this introductory blog is for members of the pharmaceutical community to share their direct to patient quality experiences, learnings, and questions while ensuring that concerns and recommendations are met. Explore the models that will improve the patient experience.
The following blog post was provided by Peyton Myers, an undergraduate student at Appalachian State University. Myers attended the 2023 ISPE Annual Meeting & Expo in Las Vegas as an ISPE Foundation Professional Development Grant recipient.
The integration of data science in biopharmaceutical manufacturing, emphasizing data quality, tech transfer efficiency, and process optimization, is the heart of this track. Led by industry experts, discussions explore leveraging digital twins, predictive analytics, and continuous improvement initiatives. Additionally, interactive roundtable discussions provide attendees with a dynamic forum...
The pharmaceutical sector stands at a crossroads of immense possibilities. We are witnessing an unprecedented surge in innovation, fueled by a remarkable partnership between industry and regulatory authorities. For example, there are initiatives fostered by the US Food and Drug Administration (US FDA) to promote innovation with programs such as CATT (CBER Advanced Technologies Team) and ETP...